Activation of the classical pathway of complement by Hageman factor fragment.
Open Access
- 1 March 1981
- journal article
- research article
- Published by Rockefeller University Press in The Journal of Experimental Medicine
- Vol. 153 (3), 665-676
- https://doi.org/10.1084/jem.153.3.665
Abstract
A fragment of activated Hageman factor (HFf) has been demonstrated to activate the classical pathway of complement in a manner that is analogous to complement activation by antigen-antibody complexes or aggregated IgG. Thus C1, C4, C2, C3, and C5 were found to be depleted on addition of HFf to serum. The reduction of serum hemolytic activity was maximal upon addition of 5 micrograms HFf and an incubation time of 60 min at 37 degrees C. Consumption of the total complement activity and of the individual components proceeded in a dose-dependent fashion. No comparable activity was observed when equimolar concentrations of either the native Hageman factor (HF) or two-chain activated form of Hageman factor (HFa) were incubated with serum. Further, the ability of HFf to convert serum C3 and C4 was similar to that of aggregated IgG as assessed by immunoelectrophoresis. This function of HFf appeared to be independent of plasminogen (or plasmin) since plasminogen-free serum was indistinguishable from normal serum. Radial double immunodiffusion experiments using antiserum to C1q, C1r, and C1s on HFf-treated serum demonstrated the dissociation of the C1 trimolecular complex, with concomitant reduction of C1r antigenicity that is indicative of C1 activation. Thus, HFf appears to lead to C1 activation upon incubation with serum or when incubated with partially purified C1. This may represent a control link between activation of the intrinsic coagulation-kinin pathway and the initiation of the classical complement cascade.This publication has 31 references indexed in Scilit:
- A Pre-Albumin Activator of PrekallikreinThe Journal of Immunology, 1970
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970
- Interaction of Plasma Kallikrein with the C1̄ InhibitorThe Journal of Immunology, 1970
- THE INHIBITION OF PLASMIN, PLASMA KALLIKREIN, PLASMA PERMEABILITY FACTOR, AND THE C'1r SUBCOMPONENT OF THE FIRST COMPONENT OF COMPLEMENT BY SERUM C'1 ESTERASE INHIBITORThe Journal of Experimental Medicine, 1969
- MECHANISMS OF ACTIVATION OF C'1 ESTERASE IN HEREDITARY ANGIONEUROTIC EDEMA PLASMA IN VITROThe Journal of Experimental Medicine, 1968
- FORMATION AND FUNCTIONAL SIGNIFICANCE OF A MOLECULAR COMPLEX DERIVED FROM THE SECOND AND THE FOURTH COMPONENT OF HUMAN COMPLEMENTThe Journal of Experimental Medicine, 1967
- THE CONVERSION OF C'1S TO C'1 ESTERASE BY PLASMIN AND TRYPSINThe Journal of Experimental Medicine, 1967
- Hemolytic Activity of Lipoprotein-Depleted Serum and the Effect of Certain Anions on ComplementThe Journal of Immunology, 1966
- Methods for the separation, purification and measurement of nine components of hemolytic complement in guinea-pig serumImmunochemistry, 1966
- THE REACTION MECHANISM OF ß1C-GLOBULIN (C'3) IN IMMUNE HEMOLYSISThe Journal of Experimental Medicine, 1966